Gilead Sciences Ireland UC (primary and secondary packaging, batch control, batch release)

The drug is intended for the treatment of adults with HIV-1 infection (in combination with other drugs) and for the treatment of chronic hepatitis B in adults and children aged 12 to 18 years.

Dosage form: tablets, film-coated

ATC: J05AF07